Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Symptom Goal Achievement in BPH
NCT00836823Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Dec 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Samsung Medical Center. Primary endpoint: Patient-reported goal achievements for the most bothersome symptoms at 12 months. Started Dec 2005; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00836823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836823.